<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Zealand Pharma — Marts 2022]]></title><description><![CDATA[<p dir="auto">Helge Larsen besøger Zealand Pharma, en dansk biofarmaceutisk virksomhed grundlagt i 1998 og dobbeltnoteret på den amerikanske og danske børs. Han taler med CMO Adam Steensberg om virksomhedens historie og ikke mindst deres aktuelle forretning med en pipeline, som ser stærk ud i 2022 med bl.a. resultater i tredje kvartal på et fase 3- studie inden for korttarmssyndrom <a href="https://www.proinvestor.com/index.php?p=debat_1&amp;postid=101533" rel="nofollow ugc">https://www.proinvestor.com/index.php?p=debat_1&amp;postid=101533</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400805/zealand-pharma-marts-2022</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 13:37:39 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400805.rss" rel="self" type="application/rss+xml"/><pubDate>Tue, 01 Mar 2022 18:53:37 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 17:26:34 GMT]]></title><description><![CDATA[<p dir="auto">Er bunden i biotech fundet? Store ændringer i Zealand Pharma. Efter generalforsamlingen i Genmab. Carlsberg går ud af Rusland. Input til olieaktier i debatten på <a href="http://ProInvestor.com" rel="nofollow ugc">ProInvestor.com</a>. Det er nogle af overskifterne i ugens korte kommentar fra Helge Larsen <a href="https://www.proinvestor.com/boards/102583/Ugekommentar-Carlsberg-Zealand-Pharma-og-Genmab" rel="nofollow ugc">https://www.proinvestor.com/boards/102583/Ugekommentar-Carlsberg-Zealand-Pharma-og-Genmab</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027283</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027283</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 31 Mar 2022 17:26:34 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 11:46:57 GMT]]></title><description><![CDATA[<p dir="auto">godt, velbekomme</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027286</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027286</guid><dc:creator><![CDATA[Svingtraderen]]></dc:creator><pubDate>Thu, 31 Mar 2022 11:46:57 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 11:10:56 GMT]]></title><description><![CDATA[<p dir="auto">Ah,<br />
nu fandt jeg det. Tak.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027285</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027285</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Thu, 31 Mar 2022 11:10:56 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 11:06:10 GMT]]></title><description><![CDATA[<p dir="auto">Hvor langt inde i udsendelsen?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027279</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027279</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Thu, 31 Mar 2022 11:06:10 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 09:55:14 GMT]]></title><description><![CDATA[<p dir="auto">Lidt trivielt, men de samlede shortpositioner falder igen - igen.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027281</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027281</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 31 Mar 2022 09:55:14 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 06:28:09 GMT]]></title><description><![CDATA[<p dir="auto">og du kan høre det igen her; <a href="https://www.euroinvestor.dk/podcast/millionaerklubben-farvel-til-et-kaotisk-kvartal" rel="nofollow ugc">https://www.euroinvestor.dk/podcast/millionaerklubben-farvel-til-et-kaotisk-kvartal</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027282</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027282</guid><dc:creator><![CDATA[Svingtraderen]]></dc:creator><pubDate>Thu, 31 Mar 2022 06:28:09 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 06:27:16 GMT]]></title><description><![CDATA[<p dir="auto">præcis</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027278</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027278</guid><dc:creator><![CDATA[Svingtraderen]]></dc:creator><pubDate>Thu, 31 Mar 2022 06:27:16 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 06:25:43 GMT]]></title><description><![CDATA[<p dir="auto">Jo, telefoninterview.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027284</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027284</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 31 Mar 2022 06:25:43 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 06:23:34 GMT]]></title><description><![CDATA[<p dir="auto">Zealand Pharma/Danske Bank: Kursmål sænkes til 220 kr. fra 250 kr. <a href="https://proinvestor.com/investornyt/802774/zealand-pharma-danske-bank-kursmal-saenkes-til-220-kr-fra-250-kr" rel="nofollow ugc">https://proinvestor.com/investornyt/802774/zealand-pharma-danske-bank-kursmal-saenkes-til-220-kr-fra-250-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027280</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027280</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 31 Mar 2022 06:23:34 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 06:21:10 GMT]]></title><description><![CDATA[<p dir="auto"><a class="plugin-mentions-user plugin-mentions-a" href="/forum/user/svingtraderen" aria-label="Profile: Svingtraderen">@<bdi>Svingtraderen</bdi></a>: Adam kom da ikke i millionærklubben......?!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027276</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027276</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Thu, 31 Mar 2022 06:21:10 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 05:48:03 GMT]]></title><description><![CDATA[<p dir="auto">Og fastholder "køb".</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027277</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027277</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 31 Mar 2022 05:48:03 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 05:41:22 GMT]]></title><description><![CDATA[<p dir="auto">****ZEALAND PHARMA/DANSKE BANK: KURSMÅL SÆNKES TIL 220 KR. FRA 250 KR.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027274</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027274</guid><dc:creator><![CDATA[Svingtraderen]]></dc:creator><pubDate>Thu, 31 Mar 2022 05:41:22 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 05:15:28 GMT]]></title><description><![CDATA[<p dir="auto">velbe</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027275</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027275</guid><dc:creator><![CDATA[Svingtraderen]]></dc:creator><pubDate>Thu, 31 Mar 2022 05:15:28 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 05:14:05 GMT]]></title><description><![CDATA[<p dir="auto"><a class="plugin-mentions-user plugin-mentions-a" href="/forum/user/svingtraderen" aria-label="Profile: svingtraderen">@<bdi>svingtraderen</bdi></a> - tak!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027272</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027272</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 31 Mar 2022 05:14:05 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 05:11:45 GMT]]></title><description><![CDATA[<p dir="auto">kan høre via facebook eller euroinvestor <a href="https://www.euroinvestor.dk/podcast/millionaerklubben-live-farvel-til-et-kaotisk-kvartal" rel="nofollow ugc">https://www.euroinvestor.dk/podcast/millionaerklubben-live-farvel-til-et-kaotisk-kvartal</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027270</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027270</guid><dc:creator><![CDATA[Svingtraderen]]></dc:creator><pubDate>Thu, 31 Mar 2022 05:11:45 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 05:11:35 GMT]]></title><description><![CDATA[<p dir="auto">Fra ENDPOINTSNEWS: After failing badly on the new commercialization front, Zealand slashes US staff, sends off CEO and pivots back to R&amp;D <a href="https://endpts.com/after-failing-badly-on-the-new-commercialization-front-zealand-slashes-us-staff-sends-off-ceo-and-pivots-back-to-rd/" rel="nofollow ugc">https://endpts.com/after-failing-badly-on-the-new-commercialization-front-zealand-slashes-us-staff-sends-off-ceo-and-pivots-back-to-rd/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027271</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027271</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Thu, 31 Mar 2022 05:11:35 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 05:08:11 GMT]]></title><description><![CDATA[<p dir="auto">Adam kommer i millionærklubben om lidt (24/7)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027265</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027265</guid><dc:creator><![CDATA[Svingtraderen]]></dc:creator><pubDate>Thu, 31 Mar 2022 05:08:11 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 04:50:27 GMT]]></title><description><![CDATA[<p dir="auto">Enig exitnu de vil vel være et piplineselskab frem for et pharmaselskab. Som du skiver skulle det jo gerne give et bedre cash-flow og derfor forhåbentlig også højerer kurs på<br />
kort mellemlang sigt.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027268</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027268</guid><dc:creator><![CDATA[Rasbom]]></dc:creator><pubDate>Thu, 31 Mar 2022 04:50:27 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 04:49:06 GMT]]></title><description><![CDATA[<p dir="auto">Nyudnævnt Zealand Pharma-direktør: For dyrt med kommerciel funktion:</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">



<a href="https://medwatch.dk/Medicinal___Biotek/article13878332.ece" title="Nyudnævnt Zealand Pharma-direktør: For dyrt med kommerciel funktion">
<img src="https://imgproxy.watchmedier.dk/5wYNvghAvZ6i6_6yBe5M6dMAzlNthXYfGHBVLPhfC74/resize:fill:960:0:0/plain/https%3A%2F%2Fphotos.watchmedier.dk%2FImages%2Farticle13878550.ece%2FALTERNATES%2Fschema-16_9%2Fdoc7kclnpsrsgza4f9n1pk.jpg" class="card-img-top not-responsive" style="max-height: 15rem;" alt="Link Preview Image" onerror="this.parentElement.remove()" />
</a>



<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://medwatch.dk/Medicinal___Biotek/article13878332.ece">
Nyudnævnt Zealand Pharma-direktør: For dyrt med kommerciel funktion
</a>
</h5>
<p class="card-text line-clamp-3">Zealand Pharmas omsætning skal nu hentes gennem strategiske partnerskaber, og derfor reducerer selskabet i en stor omstrukturering dets amerikanske arbejdsstyrke kraftigt. Ifølge nyudnævnt topchef sker det, da det er for dyrt at have en kommerciel funktion, når selskabet ikke har flere produkter på markedet.</p>
</div>
<a href="https://medwatch.dk/Medicinal___Biotek/article13878332.ece" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://medwatch.dk/favicons/medwatch.dk/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>











<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(medwatch.dk)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027267</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027267</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 31 Mar 2022 04:49:06 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 04:46:17 GMT]]></title><description><![CDATA[<p dir="auto">Der var mange gode pointer fra CC - afventer lige referat fra Seeking Alpha, men det jeg bed mærke i er at strategiskiftet (partnermodellen) også giver et langt bedre cash-flow med upfront payment, milestones - altså betalinger på forkant.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027266</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027266</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 31 Mar 2022 04:46:17 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 04:45:49 GMT]]></title><description><![CDATA[<p dir="auto">Som jeg forstår det så leder de nu efter en partner som kan stå for salget af både V-go og Zegalouge og deres kommen produkter fra pipelinen. Er der nogen som har et bud på en oplagt partner/partnerer.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027261</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027261</guid><dc:creator><![CDATA[Rasbom]]></dc:creator><pubDate>Thu, 31 Mar 2022 04:45:49 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 04:42:04 GMT]]></title><description><![CDATA[<p dir="auto">Det var lidt af en kovending. Som aktionære ville jeg selvfølgelig gerne have set, at Zealands ønsker om at blive et fuld intigreret pharmaselskab, med egen salgsstyrke have lykkes. Men vi må bare erkende at det gik ikke særlig godt og det ville havde været os aktionærer, som skulle have spyttet mange flere penge ind for at holde den drøm i live. Det virker som en klog beslutning, som tingen stod. Forhåbentlig betyder det at aktionærerne kan høste nogel gev<br />
inster inden for de næste par år...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027262</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027262</guid><dc:creator><![CDATA[Rasbom]]></dc:creator><pubDate>Thu, 31 Mar 2022 04:42:04 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 04:38:39 GMT]]></title><description><![CDATA[<p dir="auto">God morgen - håber der kommer nogle meldinger fra de analytikerer der følger ZP - med så store ændringer bør det være asap</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027269</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027269</guid><dc:creator><![CDATA[Svingtraderen]]></dc:creator><pubDate>Thu, 31 Mar 2022 04:38:39 GMT</pubDate></item><item><title><![CDATA[Reply to Zealand Pharma — Marts 2022 on Thu, 31 Mar 2022 04:37:53 GMT]]></title><description><![CDATA[<p dir="auto">Godt CC.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8027263</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8027263</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 31 Mar 2022 04:37:53 GMT</pubDate></item></channel></rss>